Max Healthcare Institute Limited announced that its Nomination and Remuneration Committee (NRC) has approved the grant of 95,000 stock options to eligible employees under the Max Healthcare Institute Limited – Employee Stock Option Scheme 2022. The meeting was held on October 30, 2026, and the grant details are provided in an attached annexure. This move aims to incentivize and retain key talent within the organization.
Max Healthcare Approves Employee Stock Options Grant
On October 30, 2026, Max Healthcare Institute Limited’s Nomination and Remuneration Committee (NRC) convened and formally approved the grant of 95,000 stock options. These options are being issued to eligible employees under the company’s existing ‘Max Healthcare Institute Limited – Employee Stock Option Scheme 2022’. The committee’s meeting commenced at 10:31 am IST and concluded at 10:48 am IST.
Details of the Stock Option Grant
The grant is in accordance with the terms of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The 95,000 equity shares covered by these options are convertible into one fully paid-up equity share each, with a face value of ₹10. The exercise price for these options is set at ₹800 per stock option.
Vesting of these options is subject to the fulfillment of pre-vesting conditions and will occur no earlier than one year and no later than five years from the grant date. The options may be exercised within three years from their respective vesting dates. The details of the grant have been provided as an annexure to the announcement.
Source: BSE
